中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

FIB-4指数对自身免疫性肝炎肝纤维化的诊断价值

周桂琴 钟启华 王融冰 董小冬 李斌 杨莉 王宪波

卢春雨, 唐少珊. 彩色多普勒超声与超声造影对经颈静脉肝内门体分流术后支架功能的评价作用[J]. 临床肝胆病杂志, 2017, 33(5): 959-962. DOI: 10.3969/j.issn.1001-5256.2017.05.036.
引用本文: 卢春雨, 唐少珊. 彩色多普勒超声与超声造影对经颈静脉肝内门体分流术后支架功能的评价作用[J]. 临床肝胆病杂志, 2017, 33(5): 959-962. DOI: 10.3969/j.issn.1001-5256.2017.05.036.
Lu ChunYu, Tang ShaoShan. Evaluation of stent function after transjugular intrahepatic portosystemic shunt using color Doppler and contrast-enhanced ultrasound[J]. J Clin Hepatol, 2017, 33(5): 959-962. DOI: 10.3969/j.issn.1001-5256.2017.05.036.
Citation: Lu ChunYu, Tang ShaoShan. Evaluation of stent function after transjugular intrahepatic portosystemic shunt using color Doppler and contrast-enhanced ultrasound[J]. J Clin Hepatol, 2017, 33(5): 959-962. DOI: 10.3969/j.issn.1001-5256.2017.05.036.

FIB-4指数对自身免疫性肝炎肝纤维化的诊断价值

DOI: 10.3969/j.issn.1001-5256.2017.08.015
基金项目: 

北京市医院管理局临床医学发展专项经费资助(ZYLX201707); 

详细信息
  • 中图分类号: R575

Value of fibrosis-4 index in diagnosis of liver fibrosis in autoimmune hepatitis

Research funding: 

 

  • 摘要: 目的通过对自身免疫性肝炎(AIH)患者临床数据进行分析,研究肝纤维化无创诊断模型FIB-4指数对AIH肝纤维化的诊断价值。方法回顾性分析2010年1月-2015年12月于首都医科大学附属北京地坛医院住院且经肝活组织检查确诊的71例AIH患者的临床资料,包括年龄、ALT、AST、PLT,计算FIB-4指数,分析FIB-4指数与肝纤维化病理分期的相关性,以及FIB-4指数诊断AIH肝纤维化的特异度和敏感度。计量资料组间比较采用Kruskal-Wallis H秩和检验。相关性分析采用Spearman秩相关分析。绘制受试者工作特征曲线,分析曲线下面积(AUC)。结果 FIB-4指数在不同肝纤维化分期间差异有统计学意义(χ2=10.134,P=0.038),年龄、ALT、AST、PLT在不同肝纤维化分期差异均无统计学意义(P值均>0.05)。FIB-4指数与肝纤维化程度呈正相关(rs=0.338,P=0.004),而PLT与肝纤维化程度呈负相关(rs=-0.305,P=0.010)。FIB-4指数诊断AIH肝纤维化S≥1、S≥2、S≥3的AUC分别为0.603、0.698、0.704(P值...

     

  • [1]STERLING RK, LISSEN E, CLUMECK N, et al.Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection[J].Hepatology, 2006, 43 (6) :1317-1325.
    [2] HENNES EM, ZENIYA M, CZAJA AJ, et al.Simplified criteria for the diagnosis of autoimmune hepatitis[J].Hepatology, 2008, 48 (1) :169-176.
    [3]ALVAREZ F, BERG PA, BIANCHI FB, et al.International Autoimmune Hepatitis Group Report:review of criteria for diagnosis of autoimmune hepatitis[J].J Hepatol, 1999, 31 (5) :929-938.
    [4]CZAJA AJ.Performance parameters of the diagnostic scoring systems for autoimmune hepatitis[J].Hepatology, 2008, 48 (5) :1540-1548.
    [5]Chinese Society of Infectious Diseases and Parasitology, Chinese Society of Hepatology, Chinese Medical Association.Prevention and treatment of viral hepatitis[J].Chin J Infect Dis, 2001, 19 (1) :56-62. (in Chinese) 中华医学会传染病与寄生虫病学分会, 肝病学分会.病毒性肝炎防治方案[J].中华传染病杂志, 2001, 19 (1) :56-62.
    [6]KRAWITT EL.Autoimmune hepatitis[J].N Engl J Med, 2006, 354 (1) :54-66.
    [7]Chinese Society of Hepatology, Chinese Medical Association;Chinese Society of Gastroenterology, Chinese Medical Association;Chinese Society of Infectious Diseases, Chinese Medical Association.Consensus on the diagnosis and management of autoimmune hepatitis (2015) [J].J Clin Hepatol, 2016, 32 (1) :9-22. (in Chinese) 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会.自身免疫性肝炎诊断和治疗共识 (2015) [J].临床肝胆病杂志, 2016, 32 (1) :9-22.
    [8]QIU D, WANG Q, WANG H, et al.Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients[J].J Hepatol, 2011, 54 (2) :340-347.
    [9]MANNS MP, CZAJA AJ, GORHAM JD, et al.Diagnosis and management of autoimmune hepatitis[J].Hepatology, 2010, 51 (6) :2193-2213.
    [10]PUOTI C, BELLIS L, GUARISCO R, et al.HCV carriers with normal alanine aminotransferase levels:healthy persons or severely ill patients?Dealing with an everyday clinical problem[J].Eur J Intern Med, 2010, 21 (2) :57-61.
    [11]FREDERIK CK, CAROLINE RD, MARTIN KI, et al.APRI:a simple bedside marker for advanced fibrosis that can avoide liver biopsy in patients with NAFLD/NASH[J].S Afr Med J, 2011, 101 (7) :477-480.
    [12]Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention and treatment for hepatitis C:a 2015 update[J].J Clin Hepatol, 2015, 31 (12) :1961-1979. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.丙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1961-1979.
    [13]JIN WW, LIN ZH, XIN YN, et al.Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related significant fibrosis:a meta-analysis[J].J Pract Med, 2011, 27 (5) :797-799. (in Chinese) 金文文, 林中华, 辛永宁, 等.APRI指数诊断HBV相关显著肝纤维化准确性的Meta分析[J].实用医学杂志, 2011, 27 (5) :797-799.
    [14]MALLET V, DHALLUIN-VENIER V, ROUSSIN C, et al.The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis B[J].Aliment Pharmacol Ther, 2009, 29 (4) :409-415.
  • 期刊类型引用(5)

    1. 王耀磊,王盼攀. 肝门部胆管癌患者术后并发症发生情况及其影响因素的Logistic回归分析. 医学理论与实践. 2024(11): 1822-1825 . 百度学术
    2. 李明,于群,肖熙,刘影倩,黄裕存. 外科Apgar评分及POSSUM评分对老年严重胸部外伤术后预后的评估价值. 名医. 2023(09): 30-32 . 百度学术
    3. 朱磊,赵海淳,李珊珊,孟君. 外科Apgar评分对术前新辅助化疗进展期胃癌术后并发症的预测价值. 中国现代普通外科进展. 2022(12): 990-993 . 百度学术
    4. 章周海,涂从银. 肝门部胆管癌的手术疗效分析. 肝胆外科杂志. 2021(03): 223-225 . 百度学术
    5. 遆军锋,温陈,张小云,姜丹丹. 肝门部胆管癌术后并发症发生危险因素及术前外科改良 Apgar评分、血清总胆红素水平对并发症的预测价值. 陕西医学杂志. 2021(12): 1513-1516 . 百度学术

    其他类型引用(0)

  • 加载中
计量
  • 文章访问数:  3763
  • HTML全文浏览量:  17
  • PDF下载量:  425
  • 被引次数: 5
出版历程
  • 收稿日期:  2016-12-21
  • 出版日期:  2017-08-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回